Bradycardia
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
Clinical Reasoning
Bradycardia arises from dysfunction within the heart's electrical conduction system, most commonly involving a slow rate of impulse generation by the sinoatrial (SA) node or impaired transmission through the atrioventricular (AV) node. This can be due to structural heart disease, medication effects, electrolyte imbalances, or increased vagal tone, leading to a reduced ventricular contraction rate and potentially compromised cardiac output. The prognosis for bradycardia is highly variable and depends significantly on its underlying etiology, severity, and the patient's overall health status. Many individuals with physiological or mild, asymptomatic bradycardia have an excellent long-term prognosis. Patients requiring a permanent pacemaker generally experience improved symptoms and a good quality of life, though the prognosis is also influenced by any underlying structural heart disease. Aging (degenerative changes in the conduction system),Heart disease (e.g., coronary artery disease, prior myocardial infarction, cardiomyopathy),Medications (e.g., beta-blockers, calcium channel blockers, digoxin, antiarrhythmics),Hypothyroidism,Electrolyte imbalances (e.g., hyperkalemia),Sick sinus syndrome or heart block
Sample MCQ
A 70-year-old man presents with progressive dyspnea, fatigue, and recurrent episodes of presyncope. Physical examination reveals a variable intensity of the first heart sound (S1) and prominent jugular venous pulse (JVP) with "cannon a" waves. Which of the following is the definitive treatment?
- AImplantable cardioverter-defibrillator
- BPermanent pacemaker
- CRadiofrequency catheter ablation
- DOral metoprolol
Correct Answer: Permanent pacemaker
### TLDR The patient's symptoms and physical findings, including variable S1 and "cannon a" waves, are highly indicative of complete (third-degree) atrioventricular block. The definitive treatment for symptomatic complete heart block is the implantation of a **permanent pacemaker**. ### Comparison Table | Option | Mechanism | Clinical Nuance | Key Distinction | | :------------------------------ | :-------------------------------- | :----------------------------- | :---------------------------------- | | Implantable cardioverter-defibrillator | Detects and shocks tachyarrhythmias | Prevents sudden cardiac death | Not indicated for bradycardia/block | | **Permanent pacemaker** | Provides electrical pacing impulses | Treats symptomatic bradycardia/block | Restores adequate heart rate/rhythm | | Radiofrequency catheter ablation | Destroys arrhythmogenic tissue | Cures specific tachyarrhythmias | Not for conduction system failure | | Oral metoprolol | Beta-blocker, slows heart rate | Manages hypertension, angina | Worsens bradycardia, contraindicated | ### Detailed Breakdown The clinical presentation strongly suggests complete (third-degree) atrioventricular (AV) block. Progressive dyspnea, fatigue, and recurrent presyncope are classic symptoms of reduced cardiac output due to a slow heart rate (bradycardia). The physical examination findings are particularly pathognomonic: 1. **Variable intensity of the first heart sound (S1):** This occurs when there is AV dissociation. The PR interval varies, leading to the mitral and tricuspid valves closing at different stages of ventricular filling, resulting in variable force and intensity of S1. This is a hallmark of complete heart block. 2. **Prominent jugular venous pulse (JVP) with "cannon a" waves:** "Cannon a" waves are seen when the right atrium contracts against a closed tricuspid valve. This happens when the atrium contracts simultaneously with the ventricle (ventricular systole), which is characteristic of AV dissociation, commonly observed in complete heart block. Given this constellation of symptoms and signs, the patient has symptomatic complete AV block, which is a life-threatening condition requiring intervention. The definitive treatment for symptomatic complete AV block is a **permanent pacemaker**. A pacemaker delivers electrical impulses to the heart, ensuring a consistent heart rate and restoring AV synchrony (depending on the pacing mode), thereby alleviating symptoms and improving cardiac output. Let's consider why the other options are incorrect: * **Implantable cardioverter-defibrillator (ICD):** ICDs are used to treat life-threatening *tachyarrhythmias* (e.g., ventricular tachycardia, ventricular fibrillation) by delivering electrical shocks. They are not designed to treat bradycardia or AV block, although some ICDs have pacing capabilities, a pacemaker is the primary device for conduction disease. * **Radiofrequency catheter ablation:** This procedure is used to eliminate abnormal electrical pathways or foci that cause *tachyarrhythmias* (e.g., atrial fibrillation, supraventricular tachycardia, ventricular tachycardia). It is not indicated for the treatment of bradycardia or AV conduction block, which involves a failure of the heart's natural electrical conduction system. * **Oral metoprolol:** Metoprolol is a beta-blocker that slows heart rate and prolongs AV nodal conduction. Administering metoprolol to a patient with symptomatic bradycardia and complete AV block would further worsen their condition and is therefore contraindicated.
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks